Background Image
Table of Contents Table of Contents
Previous Page  85 / 492 Next Page
Information
Show Menu
Previous Page 85 / 492 Next Page
Page Background

09:03 - 09:06

S4-9

(PP)

COMPARISON OF RESULTS OF ENDOSCOPIC CORRECTION OF VESICOURETERAL

REFLUX IN CHILDREN USING TWO BULKING SUBSTANCES:

DEXTRANOMER/HYALURONIC ACID COPOLYMER (DEFLUX) VERSUS

POLYACRYLATE-POLYALCOHOL COPOLYMER (VANTRIS)

Stanislaw WARCHOL

1

, Teresa DUDEK-WARCHOL

1

, Grazyna KRZEMIEN

2

, Agnieszka SZMIGIELSKA

2

, Przemyslaw

BOMBINSKI

3

and Michal BRZEWSKI

3

1) Medical University of Warsaw, Department of Pediatric Surgery and Urology, Warsaw, POLAND - 2) Medical University

of Warsaw, Department of Pediatrics and Nephrology, Warsaw, POLAND - 3) Medical University of Warsaw, Department

of Pediatric Radiology, Warsaw, POLAND

PURPOSE

The aim of the study was to evaluate the efficacy of 2 bulking substances: Deflux versus Vantris in children with VUR.

MATERIAL AND METHODS

From 2009 to 2012, 65 children (39 girls and 23 boys) aged 1.45 - 9.9 years (mean 4.85 ± 2.52) underwent endoscopic

correction of VUR using Deflux. VUR was unilateral in 31 and bilateral in 34 patients comprising 108 renal refluxing units

(RRUs) grades: II in 52, III in 47, IV in 7 and V in 2. From 2012, 68 children (43 girls and 25 boys) aged 0.6 -17.9

years (mean 4.89 ± 3.46) were treated with Vantris. VUR was unilateral in 33 and bilateral in 35 patients comprising

109 RRUs grades: II in 48, III in 29, IV in 13 and V in 19. Follow-up studies included ultrasound scan 2 weeks after

injection and voiding cystourethrogram 3 months after procedure.

RESULTS

All patients completed follow-up. In the majority of patients ultrasound showed Vantris deposit within the bladder wall

as compared with Deflux. Reflux resolved in 68 RRUs (63%) after first Deflux injection, in 30 (27,8%) after second and

in 10 (9,2%) after third. VUR was corrected in101 RRUs (92,7%) after first Vantris injection and in 8 (7,3%) after

second. No complication related to injection were noted.

CONCLUSIONS

Our data show that Vantris injection is safe and effective procedure for treating all grades of VUR with good clinical

outcome and provides higher and almost complete level of reflux resolution after first injection as compared with Deflux.